New evidence shows that GLP-1based therapies not only lower glucose levels and aid in weight loss but also reduce inflammation in the heart, kidneys, liver, and brain, revealing a broader therapeutic potential beyond metabolism
Reported benefits: C60 is described as an extremely powerful antioxidant, believed to support detoxification, improve skin health, and assist with overall vitality
In addition, other secondary outcomes comprised occurrence of the individual components of the primary composite cardiovascular outcome, fatal and nonfatal MI, fatal and nonfatal stroke, death from any cause, and hospitalization for heart failure
Some are impactful in the treatment of obesity or weight management, as they encourage the death of excess fat cells